Aeon Biopharma Inc.
13F holders, Q4 2024 (December 31)37holders +7
7new positions
1sold out
$0.54avg. 13F price*
At the end of Q4 2024, 37 institutions reported holding Aeon Biopharma Inc. in their 13F filings, up 7 from Q3 2024. 7 opened new positions and 1 sold out. The largest holders were Blue Owl Capital Holdings LP ($1.6M), Polar Asset Management Partners Inc. ($1.5M) and Vanguard Group Inc. ($405K).
- Company
- Aeon Biopharma Inc.
- CUSIP
- 00791X100
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $81K |
| Exits | 1 | $13K |
All 13F filers, Q3 2024 → Q4 2024: 481,609 shares bought and 1,170,881 shares sold, net −689,272 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 37 holders
| Blue Owl Capital Holdings LP | 0.38% | Reduce -8.7% | 3,049,361 | $1.6M |
| Polar Asset Management Partners Inc. | 0.03% | Reduce -23.3% | 2,762,688 | $1.5M |
| Vanguard Group Inc. | 0.00% | Reduce -0.3% | 749,091 | $405K |
| Formidable Asset Management, LLC | 0.06% | Add +76.8% | 689,182 | $372K |
| BlackRock, Inc. | 0.00% | Add +0.1% | 265,525 | $143K |
| Ikarian Capital, LLC | 0.04% | Reduce -0.2% | 257,563 | $139K |
| Geode Capital Management, LLC | 0.00% | Add +3.5% | 251,775 | $136K |
| Bank of America Corp. | 0.00% | Add +0.0% | 166,601 | $90K |
| Caprock Group, LLC | 0.00% | No change | 62,686 | $34K |
| State Street Corp. | 0.00% | No change | 60,950 | $33K |
| Boothbay Fund Management, LLC | 0.00% | Reduce -0.8% | 54,648 | $30K |
| Two Sigma Investments, LP | 0.00% | Reduce -18.7% | 53,018 | $29K |
| Bridgeway Capital Management, LLC | 0.00% | New | 50,000 | $27K |
| LMR Partners LLP | 0.00% | No change | 48,901 | $26K |
| UBS Group AG | 0.00% | Reduce -15.3% | 48,795 | $26K |
| Northern Trust Corp. | 0.00% | Reduce -9.0% | 47,260 | $26K |
| Virtu Financial LLC | 0.00% | New | 38,000 | $21K |
| LPL Financial LLC | 0.00% | Add +40.9% | 37,812 | $20K |
| Two Sigma Securities, LLC | 0.00% | New | 24,535 | $13K |
| HighTower Advisors, LLC | 0.00% | No change | 23,776 | $13K |
| HRT Financial LP | 0.00% | New | 20,639 | $11K |
| Cutter & CO Brokerage, Inc. | 0.00% | No change | 14,027 | $8K |
| Lido Advisors, LLC | 0.00% | No change | 12,894 | $7K |
| Dupont Capital Management Corp. | 0.00% | No change | 12,282 | $7K |
| Corient Private Wealth LP | 0.00% | Reduce -8.6% | 11,586 | $6K |
| BBR Partners, LLC | 0.00% | No change | 11,586 | $6K |
| Jane Street Group, LLC | 0.00% | Add +2.8% | 11,011 | $6K |
| Morgan Stanley | 0.00% | Add +503.6% | 10,864 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +59.7% | 8,396 | $5K |
| Steward Partners Investment Advisory, LLC | 0.00% | Add +13.9% | 8,200 | $4K |
| Wells Fargo & Company | 0.00% | New | 6,500 | $4K |
| Wolff Wiese Magana LLC | 0.00% | New | 4,835 | $3K |
| MAI Capital Management | 0.00% | New | 4,240 | $2K |
| GHP Investment Advisors, Inc. | 0.00% | No change | 1,095 | $592 |
| CIBC Private Wealth Group LLC | 0.00% | No change | 2,417 | $459 |
| SBI Securities Co., Ltd. | 0.00% | — | 103 | $56 |
| JPMorgan Chase & Co. | 0.00% | Reduce -8.6% | 53 | $29 |
"% of holder's portfolio" is AEON BIOPHARMA INC's weight in each manager's 13F, not the share of Aeon Biopharma Inc. the manager owns.